Selectins in Biology and Human Disease: Opportunity in E-selectin Antagonism.

Cureus · 2024 · PMC11232095 · PMID 38983984

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Also, in a trial of reperfusion injury after neonatal cardiopulmonary bypass surgery ( NCT00226369 ), Cylexin showed a trend toward decreased 30-day mortality ( https://ichgcp.net/clinical-trials-registry/NCT00226369 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.